If Elizabeth Holmes testifies in her own criminal trial, videotaped depositions may be a clue of how she’ll fare on the stand. Twelve days after she was indicted on fraud charges, Holmes, the CEO and founder of Theranos, sat for a nearly four hour deposition in which she hardly answered any questions. But in the
0 Comments
Quartr A new start-up is attempting to modernize the investor relations industry to meet the surge of new retail investors. Swedish start-up Quartr recently raised $4.5 million to help build out its product, which includes recordings of earnings calls and financial documents from major companies. Investors in Quartr include executives at the Ritholtz Group —
0 Comments
The November 3 version of the Build Back Better Act has resurrected retirement law changes that will curb high balance accounts and popular wealth building strategies including backdoor Roth IRAs and aftertax 401(k) contributions. There’s also a new $2.5 million retirement account reporting mandate, presumably to help the Internal Revenue Service with compliance. The changes
0 Comments
Cavan Images | Getty Images Democratic lawmakers on Wednesday unveiled a revised social spending and climate provision that expands an electric vehicle tax credit of up to $12,500 for more expensive cars and proposes a lower income cut-off for buyers eligible for the credit. The House Democrats’ update makes vans, sport utility vehicles and trucks priced
0 Comments
Jakub Porzycki | NurPhoto | Getty Images The fast-growing decentralized finance industry could be about to get a rude awakening. Decentralized finance, or “DeFi” as it’s commonly referred to, is a trend in cryptocurrencies that first started gaining traction in 2020. It’s been called the “Wild West” of crypto — hoards of computer programmers trying
0 Comments
dusanpetkovic | iStock | Getty Images Improvements to Medicare’s coverage could be on the horizon for the health insurance program’s 63.3 million beneficiaries. Under the latest version of congressional Democrats’ $1.75 trillion spending bill, the federal government would be permitted to negotiate the price of certain drugs with pharmaceutical companies, a move expected to result
0 Comments